The aim of the study is to estimate the incidence of CE, evaluate the endometrial microorganism of CE, and investigate the therapeutic benefits of antibiotics for women with unexplained recurrent miscarriage and CE.
Women with a history of 2 or more consecutive miscarriages before 24 weeks of gestation
Women aged 20-45 years old
Uncorrected uterine anomalies, such as the septate or bicornuate uterus, fibroids (submucous/intramural)
Untreated hydrosalpinx
Antiphospholipid syndrome
Known clinical autoimmune disease